Accelerating Access, Improving Lives
Access to high-quality medicines should be equally available and affordable to everyone regardless of wealth status or geography.
Join our mission
0
%
Did you know that 90% of the world’s disease burden occurs in low- and middle-income countries.We're dedicated to changing this reality by making high-quality medicines accessible and affordable for everyone.
0
%
LMICs account for only 6% of global pharmaceutical sales, making them an under-served market for innovative and high-quality generic medicines
0
years
With under 7 years to meet UN Sustainable Development Goal 3, let's act now to ensure equitable access to essential medicines.
Revolutionizing Medicine Access
Explore the Axmed Medicines Platform, our groundbreaking marketplace for low- and middle-income countries. Partner with Axmed Global Health Advisory for unmatched expertise in healthcare solutions.
Stay informed, discover our innovations, and see how we’re making high-quality healthcare accessible for all.
Learn more
Our Solutions
Empowering patients with access to high-quality healthcare.
“Of all the forms of inequality, injustice in health care is the most shocking and inhumane.”
Martin Luther King Jr.
Insights
Axmed raises $2 million to transform access to critical medicines in low and middle income countries
For too long, low- and middle-income countries (LMICs) have borne the brunt of global health disparities— accounting for over 80%...
Read more
Axmed Awarded $5 Million
Grant funding from the Bill & Melinda Gates Foundation targets improving access to essential medicines for the Maternal, Newborn, and...
Read more
Poor countries desperately need better access to generic medicines
Manufacturers showed during the pandemic that they can deliver low-cost treatments at scale. The Covid-19 pandemic underscored the urgent need...
Read more
Pooled procurement of drugs in low- and middle- income countries can lower prices and improve access
Patients in the developing world often face prices for essential medicines far in excess of international reference levels, even if...
Read more
FDA Grants Accelerated Approval for Alzheimer’s Disease Treatment
FDA NEWS RELEASE Today, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease....
Read more
Index finds more pharma companies moving to address access to medicine. Will they now go further?
The 2022 Access to Medicine Index finds that since the COVID-19 pandemic hit, more pharmaceutical companies have stepped up to...
Read more
Corona virus hits america again
Pharmaceutical companies invest heavily in R&D in order to discover and develop new drugs that can be brought to market....
Read more
Drug shortages worsen in South Africa: In February 2021, it was reported that drug shortages in South Africa had worsened due to the COVID-19 pandemic
In February 2021, it was reported that drug shortages in South Africa had worsened due to a combination of factors,...
Read moreReady to Transform Healthcare?
Join us in making quality medicines accessible for all. See how our solutions can benefit your organization and patients worldwide.
Request a demo